Walleye Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.6M | Buy |
364,246
+141,779
| +64% | +$8.27M | 0.13% | 188 |
|
|
2025
Q4 | $13.2M | Buy |
222,467
+150,655
| +210% | +$8.2M | 0.08% | 479 |
|
|
2025
Q3 | $3.89M | Buy |
71,812
+71,746
| +108,706% | +$4.1M | 0.03% | 1089 |
|
|
2025
Q2 | $3.63K | Sell |
66
-32,705
| -100% | -$1.93M | ﹤0.01% | 4367 |
|
|
2025
Q1 | $2.32M | Buy |
32,771
+4,699
| +17% | +$316K | 0.03% | 1311 |
|
|
2024
Q4 | $1.85M | Sell |
28,072
-127,370
| -82% | -$8.53M | 0.02% | 1855 |
|
|
2024
Q3 | $10.9M | Buy |
155,442
+117,119
| +306% | +$9.79M | 0.12% | 640 |
|
|
2024
Q2 | $3.16M | Buy |
38,323
+3,639
| +10% | +$303K | 0.03% | 1683 |
|
|
2024
Q1 | $3.03M | Buy |
34,684
+22,111
| +176% | +$1.98M | 0.03% | 1687 |
|
|
2023
Q4 | $1.21M | Buy |
12,573
+7,572
| +151% | +$670K | 0.02% | 2194 |
|
|
2023
Q3 | $442K | Sell |
5,001
-43,638
| -90% | -$3.88M | 0.01% | 2907 |
|
|
2023
Q2 | $4.22M | Sell |
48,639
-88,633
| -65% | -$8.34M | 0.07% | 843 |
|
|
2023
Q1 | $13.3M | Buy |
137,272
+71,798
| +110% | +$7.44M | 0.27% | 97 |
|
|
2022
Q4 | $6.78M | Sell |
65,474
-27,272
| -29% | -$2.56M | 0.15% | 205 |
|
|
2022
Q3 | $7.86M | Buy |
92,746
+52,496
| +130% | +$4.67M | 0.18% | 147 |
|
|
2022
Q2 | $3.34M | Sell |
40,250
-75,399
| -65% | -$6M | 0.1% | 243 |
|
|
2022
Q1 | $8.92M | Buy |
115,649
+104,154
| +906% | +$8.71M | 0.26% | 87 |
|
|
2021
Q4 | $1.02M | Buy |
+11,495
| New | +$949K | 0.03% | 584 |
|
|
2021
Q3 | – | Sell |
-3,560
| Closed | -$297 | – | 1602 |
|
|
2021
Q2 | $297 | Buy |
+3,560
| New | +$282K | 0.01% | 944 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1000 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1848 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1968 |
|
|
2019
Q2 | – | Sell |
-822
| Closed | -$70.3K | – | 1784 |
|
|
2019
Q1 | $73K | Buy |
+822
| New | +$76.2K | 0.11% | 1116 |
|
Other funds holding BMRN
VCM
VPM